232 related articles for article (PubMed ID: 23427736)
1. [Genetic biomarkers and personalized medicine: application in cardiovascular pharmacology].
Carrillo Norte JA
Rev Enferm; 2013 Jan; 36(1):41-50. PubMed ID: 23427736
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomic biomarkers: new tools in current and future drug therapy.
Sim SC; Ingelman-Sundberg M
Trends Pharmacol Sci; 2011 Feb; 32(2):72-81. PubMed ID: 21185092
[TBL] [Abstract][Full Text] [Related]
3. Genomics of cardiovascular disease.
Manace LC; Godiwala TN; Babyatsky MW
Mt Sinai J Med; 2009 Dec; 76(6):613-23. PubMed ID: 20014425
[TBL] [Abstract][Full Text] [Related]
4. Prospects of personalized medicine in cardiovascular diseases.
Lenfant C
Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
Wei CY; Lee MT; Chen YT
Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular pharmacogenetics.
Myburgh R; Hochfeld WE; Dodgen TM; Ker J; Pepper MS
Pharmacol Ther; 2012 Mar; 133(3):280-90. PubMed ID: 22123178
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics/genomics and personalized medicine.
Sadée W; Dai Z
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319
[TBL] [Abstract][Full Text] [Related]
8. [From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology].
Zaza G; Granata S; Mangino M; Grandaliano G; Schena FP
G Ital Nefrol; 2010; 27(4):353-66. PubMed ID: 20672232
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
10. DMET microarray technology for pharmacogenomics-based personalized medicine.
Burmester JK; Sedova M; Shapero MH; Mansfield E
Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
[TBL] [Abstract][Full Text] [Related]
11. Can pharmacogenetics help rescue drugs withdrawn from the market?
Shah RR
Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
[TBL] [Abstract][Full Text] [Related]
12. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomic biomarkers for personalized medicine.
Chen JJ; Lin WJ; Chen HC
Pharmacogenomics; 2013 Jun; 14(8):969-80. PubMed ID: 23746190
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics and drug response in cardiovascular disorders.
Siest G; Jeannesson E; Berrahmoune H; Maumus S; Marteau JB; Mohr S; Visvikis S
Pharmacogenomics; 2004 Oct; 5(7):779-802. PubMed ID: 15469403
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacogenetics in cardiovascular diseases therapy--treatment according guidelines or according the individual requirement?].
Bultas J
Cas Lek Cesk; 2010; 149(10):476-81. PubMed ID: 21121138
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics and therapeutic strategies for dementia.
Cacabelos R
Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.
Lauschke VM; Milani L; Ingelman-Sundberg M
AAPS J; 2017 Nov; 20(1):4. PubMed ID: 29181807
[TBL] [Abstract][Full Text] [Related]
18. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
[TBL] [Abstract][Full Text] [Related]
19. Advances in the development of genetic markers for the diagnosis of disease and drug response.
Halapi E; Hakonarson H
Expert Rev Mol Diagn; 2002 Sep; 2(5):411-21. PubMed ID: 12271813
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.
Gervasini G; Benítez J; Carrillo JA
Eur J Clin Pharmacol; 2010 Aug; 66(8):755-74. PubMed ID: 20582584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
